These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8896393)

  • 1. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line.
    Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Improta S; Juzbasic S; Todesco M; Perin V; Gattei V; Herrmann F; Gruss HJ; Carbone A
    Blood; 1996 Nov; 88(9):3299-305. PubMed ID: 8896393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of eosinophils in the pathobiology of Hodgkin's disease.
    Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Perin V; Todesco M; De Iuliis A; Improta S; Sacco C; Gattei V; Gruss HJ; Carbone A
    Ann Oncol; 1997; 8 Suppl 2():89-96. PubMed ID: 9209649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
    Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
    Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
    Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
    Br J Haematol; 2001 Sep; 114(3):616-23. PubMed ID: 11552987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
    Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
    Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
    Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
    Hsu PL; Hsu SM
    Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Scheffrahn I; Hubinger G; Duyster J; Hermann F
    Leukemia; 1996 May; 10(5):829-35. PubMed ID: 8656679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma.
    Hansen HP; Engels HM; Dams M; Paes Leme AF; Pauletti BA; Simhadri VL; Dürkop H; Reiners KS; Barnert S; Engert A; Schubert R; Quondamatteo F; Hallek M; Pogge von Strandmann E
    J Pathol; 2014 Mar; 232(4):405-14. PubMed ID: 24659185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
    Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
    Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 ligand in lymphoma patients with CD30+ tumors.
    Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
    J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
    Gruss HJ; Duyster J; Herrmann F
    Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.
    Wendtner CM; Schmitt B; Gruss HJ; Druker BJ; Emmerich B; Goodwin RG; Hallek M
    Cancer Res; 1995 Sep; 55(18):4157-61. PubMed ID: 7545087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased accumulation of CD30 ligand-positive mast cells associates with eosinophilic inflammation in nasal polyps.
    Zhai GT; Li JX; Zhang XH; Liao B; Lu X; Liu Z
    Laryngoscope; 2019 Mar; 129(3):E110-E117. PubMed ID: 30570137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30L-ETA': a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma.
    Barth S; Matthey B; Huhn M; Diehl V; Engert A
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):69-78. PubMed ID: 10515679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.
    Gattei V; Degan M; Rossi FM; de Iuliis A; Mazzocco FT; Serraino D; Zagonel V; Aldinucci D; Pinto A
    Leuk Lymphoma; 1999 Sep; 35(1-2):21-35. PubMed ID: 10512160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas.
    Hsu SM; Waldron J; Xie SS; Hsu PL
    J Biomed Sci; 1995 Oct; 2(4):302-313. PubMed ID: 11725067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
    Huhn M; Sasse S; Tur MK; Matthey B; Schinköthe T; Rybak SM; Barth S; Engert A
    Cancer Res; 2001 Dec; 61(24):8737-42. PubMed ID: 11751393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.
    Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A
    Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.